Cargando…
Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment—detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations
PURPOSE: Mesonephric-like adenocarcinomas (MLA) of the female genital tract represent a rare and relatively recently described neoplasm exhibiting characteristic morphologic and immunohistochemical findings commonly associated with a KRAS-mutation. Most cases display an aggressive clinical behavior,...
Autores principales: | Brambs, Christine E., Horn, Lars-Christian, Hiller, Ruth, Krücken, Irene, Braun, Christian, Christmann, Corina, Monecke, Astrid, Höhn, Anne Kathrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620254/ https://www.ncbi.nlm.nih.gov/pubmed/37668797 http://dx.doi.org/10.1007/s00432-023-05306-9 |
Ejemplares similares
-
2020 WHO Classification of Female Genital Tumors
por: Höhn, Anne Kathrin, et al.
Publicado: (2021) -
Sustained response to lenvatinib and pembrolizumab in two patients with KRAS-mutated endometrial mesonephric-like adenocarcinoma
por: Shen, Sherry, et al.
Publicado: (2021) -
Mesonephric adenocarcinomas in female genital tract: A case series
por: Xie, Chuan, et al.
Publicado: (2021) -
Targeting KRAS in Pancreatic Cancer
por: Cowzer, Darren, et al.
Publicado: (2022) -
Understanding KRAS for better targeting
por: Patel, Ronak, et al.
Publicado: (2023)